ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Valsartan recall expands to Mylan, Teva products
fiercepharma
December 06, 2018When a suspected carcinogen was detected by a U.S. drugmaker last summer in the API it had acquired to make blood pressure drugs, it first appeared to be another issue of tainted products produced in China. Since then
Pharma Sources Insight January 2025
